Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by Greencashon Dec 07, 2016 12:17pm
154 Views
Post# 25566342

November Report THC$$$

November Report THC$$$

During the month of November, management participated in a Health Canada inspection of its AMPR licensed facility in Kelowna, B.C. The Initial inspection took 4 days to complete with Health Canada inspectors examining all aspects of the ACMPR.

THC Biomed is the 1st Licenced producer to Apply for a license to sell Starting Material to registered clients under the ACMPR. Other licenced producers with sales license are currently authorized to sell starting material to registered clients for 6 months but will need to apply for an amendment should they wish to continue selling starting material.

Should THC be granted the amendments it has applied for, it would become Canada’s most LICENCED, LICENCED Producer. Management was pleased with the inspection and confident that it continues to meet all of Health Canada’s requirements.

THC is also pleased to report that it has received an indication that its license will be amended to include in-house analytical testing at its onsite laboratory. This allows THC to conduct its own analytical testing for internal research and development purposes.

During the month of November, management oversaw the completion and filing of the Issuer’s audited financial statements and Management’s Discussion and Analysis.

Management will continue to employ fiscal discipline as we asses and strategically move forward in building an international vertically integrated Cannabis conglomerate. Management continues to work diligently to increase shareholder value and meet the milestones it has set out to shareholders. 


Bullboard Posts